Unlock the secrets to successful pulmonary and nasal drug delivery with our exclusive on-demand webinar: "Solving the inhalation puzzle: A CDMO's guide to dry powder development."
Inhalation and nasal delivery are transforming how we deliver therapeutics, from challenging small molecules to innovative biologics. Dry Powder Inhalers (DPIs) stand out as a versatile and stable platform. But navigating the development landscape—considering dosage, API properties, and release profiles—can be complex. This webinar cuts through the complexity, offering expert guidance from a CDMO perspective.
Whether you're new to the field or looking to optimize your strategy, our experts will shed light on the critical factors for developing inhalation and nasal dry powder products. Learn how different micronization technologies like milling and spray drying impact your product's performance. Discover the nuances of formulation choices, excipients, and cutting-edge encapsulation technologies.
What You'll Learn:
- Target Product Profile Impact: Understand how your TPP dictates the development path for inhalation drug products.
- Formulation & Particle Engineering: Gain insights into optimal formulation choices and particle engineering technologies (jet milling and spray drying) guided by your TPP.
- Overcoming Encapsulation Obstacles: Learn how to prevent and overcome common challenges during the encapsulation of inhaled powders.
Our Lonza leaders bring experience in dry powder formulation, particle engineering, and manufacturing to help you make informed decisions for your next inhalation product.